READISCA is an NIH-funded international clinical trial readiness study for spinocerebellar ataxia type 1 (SCA1) and type 3 (SCA3). These SCAs belong to a group of 50 autosomal dominant diseases that cause degeneration of the cerebellum and variable..
Relevance: 4.926898